                         SEQUENCE LISTING

<110>  Wang, Hoau-Yan
       Burns Barbier, Lindsay
       Wang, Jian
 
<120>  ANALGESIA WITH MINIMAL TOLERANCE AND DEPENDENCE BY A MU OPIOID 
       RECEPTOR AGONIST THAT ALSO BINDS FILAMIN A

<130>  PAT105.1PCT

<160>  16    

<170>  PatentIn version 3.4

<210>  1
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence

<400>  1

Val Thr Gly Pro Arg Leu Val Ser Asn His Ser Leu His Glu Thr Ser 
1               5                   10                  15      


Ser Val Phe Val Asp Ser Leu Thr Lys Ala Thr Cys Ala Pro Gln His 
            20                  25                  30          


Gly Ala Pro Gly Pro Gly Pro Ala Asp Ala Ser Lys Val 
        35                  40                  45  


<210>  2
<211>  45
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  2

Gly Leu Ser Lys Ala Tyr Val Gly Gln Lys Ser Ser Phe Thr Val Asp 
1               5                   10                  15      


Cys Ser Lys Ala Gly Asn Asn Met Leu Leu Val Gly Val His Gly Pro 
            20                  25                  30          


Arg Thr Pro Cys Glu Glu Ile Leu Val Lys His Val Gly 
        35                  40                  45  


<210>  3
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is any amino acid

<400>  3

Val Ala Xaa Gly Leu 
1               5   


<210>  4
<211>  95
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (48)..(48)
<223>  X is any amino acid

<400>  4

Val Thr Gly Pro Arg Leu Val Ser Asn His Ser Leu His Glu Thr Ser 
1               5                   10                  15      


Ser Val Phe Val Asp Ser Leu Thr Lys Ala Thr Cys Ala Pro Gln His 
            20                  25                  30          


Gly Ala Pro Gly Pro Gly Pro Ala Asp Ala Ser Lys Val Val Ala Xaa 
        35                  40                  45              


Gly Leu Gly Leu Ser Lys Ala Tyr Val Gly Gln Lys Ser Ser Phe Thr 
    50                  55                  60                  


Val Asp Cys Ser Lys Ala Gly Asn Asn Met Leu Leu Val Gly Val His 
65                  70                  75                  80  


Gly Pro Arg Thr Pro Cys Glu Glu Ile Leu Val Lys His Val Gly 
                85                  90                  95  


<210>  5
<211>  50
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (48)..(48)
<223>  X is any amino acid

<400>  5

Val Thr Gly Pro Arg Leu Val Ser Asn His Ser Leu His Glu Thr Ser 
1               5                   10                  15      


Ser Val Phe Val Asp Ser Leu Thr Lys Ala Thr Cys Ala Pro Gln His 
            20                  25                  30          


Gly Ala Pro Gly Pro Gly Pro Ala Asp Ala Ser Lys Val Val Ala Xaa 
        35                  40                  45              


Gly Leu 
    50  


<210>  6
<211>  50
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is any amino acid

<400>  6

Val Ala Xaa Gly Leu Gly Leu Ser Lys Ala Tyr Val Gly Gln Lys Ser 
1               5                   10                  15      


Ser Phe Thr Val Asp Cys Ser Lys Ala Gly Asn Asn Met Leu Leu Val 
            20                  25                  30          


Gly Val His Gly Pro Arg Thr Pro Cys Glu Glu Ile Leu Val Lys His 
        35                  40                  45              


Val Gly 
    50  


<210>  7
<211>  50
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (26)..(26)
<223>  X is any amino acid

<400>  7

Leu Thr Lys Ala Thr Cys Ala Pro Gln His Gly Ala Pro Gly Pro Gly 
1               5                   10                  15      


Pro Ala Asp Ala Ser Lys Val Val Ala Xaa Gly Leu Gly Leu Ser Lys 
            20                  25                  30          


Ala Tyr Val Gly Gln Lys Ser Ser Phe Thr Val Asp Cys Ser Lys Ala 
        35                  40                  45              


Gly Asn 
    50  


<210>  8
<211>  45
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  X is any amino acid

<400>  8

Ala Thr Cys Ala Pro Gln His Gly Ala Pro Gly Pro Gly Pro Ala Asp 
1               5                   10                  15      


Ala Ser Lys Val Val Ala Xaa Gly Leu Gly Leu Ser Lys Ala Tyr Val 
            20                  25                  30          


Gly Gln Lys Ser Ser Phe Thr Val Asp Cys Ser Lys Ala 
        35                  40                  45  


<210>  9
<211>  35
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X is any amino acid

<400>  9

Gln His Gly Ala Pro Gly Pro Gly Pro Ala Asp Ala Ser Lys Val Val 
1               5                   10                  15      


Ala Xaa Gly Leu Gly Leu Ser Lys Ala Tyr Val Gly Gln Lys Ser Ser 
            20                  25                  30          


Phe Thr Val 
        35  


<210>  10
<211>  25
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is any amino acid

<400>  10

Gly Pro Gly Pro Ala Asp Ala Ser Lys Val Val Ala Xaa Gly Leu Gly 
1               5                   10                  15      


Leu Ser Lys Ala Tyr Val Gly Gln Lys 
            20                  25  


<210>  11
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is any amino acid

<400>  11

Asp Ala Ser Lys Val Val Ala Xaa Gly Leu Gly Leu Ser Lys Ala 
1               5                   10                  15  


<210>  12
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  12

Val Ala Ala Gly Leu 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  13

Ala Ala Lys Gly Leu 
1               5   


<210>  14
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  14

Val Ala Lys Gly Leu 
1               5   


<210>  15
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  15

Val Ala Lys Ala Leu 
1               5   


<210>  16
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  16

Val Ala Lys Gly Ala 
1               5   


